Clinical and hemodynamic effects of an orally active endothelin-1-receptor antagonist in patients with refractory chronic heart failure.

被引：0
|
作者：
Suetsch, G
Christen, S
Yan, XW
Strobel, W
Rickenbacher, P
Hunziker, P
Bertel, O
Kiowski, W
机构：
[1] UNIV ZURICH HOSP,CH-8091 ZURICH,SWITZERLAND
[2] TRIEMLI HOSP,ZURICH,SWITZERLAND
[3] UNIV BASEL HOSP,CH-4031 BASEL,SWITZERLAND
来源：
CIRCULATION | 1997年 / 96卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：511 / 511
页数：2
相关论文
共 50 条
  • [1] Neurohormonal effects of endothelin-1-receptor antagonist therapy in patients with chronic heart failure.
    Kiowski, W
    Suetsch, G
    Yan, XW
    Strobel, W
    Rickenbacher, P
    Hunziker, P
    Christen, S
    Bertel, O
    CIRCULATION, 1997, 96 (08) : 510 - 510
  • [2] Chronic effects of an orally active selective endothelin-B-receptor antagonist in experimental congestive heart failure
    Sawaki, M
    Wada, A
    Tsutamoto, T
    Ohnishi, M
    Fujii, M
    Matsumoto, T
    Kinoshita, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S323 - S326
  • [3] Adverse hemodynamic effects of a selective endothelin ETB receptor antagonist in patients with chronic heart failure:: reversal with a selective endothelin ETA receptor antagonist
    Cowburn, PJ
    Cleland, JGF
    McDonagh, TA
    McArthur, JD
    MacLean, MR
    Dargie, HJ
    CIRCULATION, 1998, 98 (17) : 718 - 718
  • [4] Chronic effects of a novel, orally active endothelin receptor antagonist, T-0201, in dogs with congestive heart failure
    Ohnishi, M
    Wada, A
    Tsutamoto, T
    Fukai, D
    Sawaki, M
    Maeda, Y
    Kinoshita, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S236 - S238
  • [5] Chronic treatment with a novel orally active non-selective endothelin receptor antagonist in heart failure
    Ohnishi, M
    Wada, A
    Tsutamoto, T
    Maeda, Y
    Fukai, D
    Sawaki, M
    Maeda, K
    Hisanaga, T
    Mabuchi, N
    Kinoshita, M
    CIRCULATION, 1997, 96 (11) : 4292 - 4292
  • [6] Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure
    Torre-Amione, G
    Young, JB
    Colucci, WS
    Lewis, BS
    Pratt, C
    Cotter, G
    Stangl, K
    Elkayam, U
    Teerlink, JR
    Frey, A
    Rainisio, M
    Kobrin, I
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) : 140 - 147
  • [7] Endothelin receptor function in capacitance vessels of patients with chronic heart failure.
    Love, MP
    Haynes, WG
    Webb, DJ
    McMurray, JJ
    CIRCULATION, 1996, 94 (08) : 2899 - 2899
  • [8] Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failure
    Bergler-Klein, J
    Pacher, R
    Berger, R
    Bojic, A
    Stanek, B
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (01): : 20 - 27
  • [9] Short-term hemodynamic effects of BQ-123, a selective endothelin ETA receptor antagonist, in patients with chronic heart failure
    Cowburn, PJ
    Morton, JJ
    McArthur, JD
    MacLean, MR
    Dargie, HJ
    McMurray, JJV
    Cleland, JGF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 250A - 250A
  • [10] Acute hemodynamic and renal effects of the endothelin-1 receptor antagonist TAK-044 in patients without heart failure
    Sutsch, G
    Fleisch, M
    Yan, XW
    Wenzel, R
    Binggeli, C
    Bianchetti, MC
    Kiowski, W
    Luscher, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 52132 - 52132
12345